Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)

Nemours Children's Health

Status: Withdrawn

Conditions: Birth Asphyxia; Hypoxic-Ischemic Encephalopathy

Treatments: Other: Umbilical Cord Milking

Study type: Interventional

Funder types: Other

Identifiers

NCT03681314

UCM2018FU

Details and patient eligibility

About

An extension of the MIDAB trial, the MIDAB-Follow-up trial will evaluate the neurodevelopmental outcomes at 22-26 months age of term/late preterm infants who were depressed at birth and received umbilical cord milking (UCM) or immediate cord clamping (ICC).

Full description

The MIDAB-Follow-up trial will examine the difference in survival and neurodevelopmental impairment of infants who were depressed at birth and enrolled in MIDAB trial. The difference in survival and neurodevelopmental impairment in infants who received UCM and ICC will be assessed using standardized neurological and developmental assessment tools at 22-26 months of age.

Sex: All

Ages: 3 to 26 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Enrolled in MIDAB trial

Exclusion criteria

• None

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Umbilical Cord Milking

Active Comparator group

Description:

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.

Treatment:

Other: Umbilical Cord Milking

Immediate Cord Clamping

No Intervention group

Description:

The umbilical cord is clamped immediately after the delivery.